Patents by Inventor Carl-Johan Dalsgaard

Carl-Johan Dalsgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of pemirolast
    Patent number: 9415051
    Abstract: According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: August 16, 2016
    Assignee: RSPR Pharma AB
    Inventors: Johan Raud, Carl-Johan Dalsgaard, Göran Tornling
  • USE OF PEMIROLAST IN THE TREATMENT OF ACUTE ASTHMA
    Publication number: 20160175311
    Abstract: According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as an acute asthma attack. Suitable lower doses of pemirolast are least about 110 mg per day.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 23, 2016
    Inventors: Johan RAUD, Carl-Johan DALSGAARD, Jesper SÄFHOLM
  • Pemirolast for the Treatment of Systemic Low Grade Inflammation
    Publication number: 20120329813
    Abstract: According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the treatment of systemic low-grade inflammation.
    Type: Application
    Filed: November 12, 2010
    Publication date: December 27, 2012
    Applicant: Cardoz AB
    Inventors: Johan Raud, Carl-Johan Dalsgaard
  • COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20110092463
    Abstract: There is provided combination products comprising (a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) a compound that inhibits the formation and/or action of angiotensin II, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in atherosclerosis and related conditions.
    Type: Application
    Filed: April 3, 2009
    Publication date: April 21, 2011
    Inventors: Johan Raud, Carl-Johan Dalsgaard
  • COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY ATHEROSCLEROSIS COMPRISING A MAST CELL INHIBITOR AND A PPAR GAMMA AGONIST
    Publication number: 20100184783
    Abstract: There is provided combination products comprising (a) a mast cell inhibitor, or a pharmaceutically-acceptable salt or solvate thereof; and (b) a PPARY agonist, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in atherosclerosis and related conditions.
    Type: Application
    Filed: June 25, 2008
    Publication date: July 22, 2010
    Inventors: Johan Raud, Carl-Johan Dalsgaard